GU Cancers Symposium 2014 - Enzalutamide monotherapy: Extended follow-up of a phase II study in hormone-naive prostate cancer patients - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Bertrand Tombal, Michael Borre, Per Rathenborg, Patrick Werbrouck, Hendrik Van Poppel, Axel Heidenreich, Peter Iversen, Johan Braeckman, Jiri Heracek, Edwina Baskin-Bey, Taoufik Ouatas, Frank Perabo, De Phung, and Matthew R. Smith at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

gucancer 2014 Tombal poster thumb

Cliniques Universitaires Saint-Luc, Brussels, Belgium; Åarhus University Hospital, Aarhus, Denmark; Herlev University Hospital, Herlev, Denmark; AZ Groeninge Kortrijk, Kortrijk, Belgium; UZ Leuven, Leuven, Belgium; Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany; Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; UZ Brussel, Brussels, Belgium; Univerzita Karlova v Praze, Prague, Czech Republic; Astellas Pharma Global Development, Leiden, Netherlands; Astellas Pharma Global Development, Northbrook, IL; Massachusetts General Hospital Cancer Center, Boston, MA

 

email news signup